Krystal Biotech to Present at Stifel 2024 Healthcare Conference
Krystal Biotech, Inc. (NASDAQ:KRYS) Just Released Its Third-Quarter Earnings: Here's What Analysts Think [Yahoo! Finance]
Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Citigroup Inc. from $204.00 to $206.00. They now have a "neutral" rating on the stock.
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $221.00 price target on the stock.